0
0

Safe RESEARCH Act

2/1/2024, 8:30 AM

Summary of Bill HR 1466

The Safe RESEARCH Act, also known as Bill 118 hr 1466, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to promote the safety and well-being of research participants in clinical trials and other research studies.

The Safe RESEARCH Act aims to achieve this goal by requiring researchers to follow certain guidelines and protocols when conducting research involving human subjects. These guidelines include obtaining informed consent from participants, ensuring that the research is conducted in an ethical manner, and protecting the privacy and confidentiality of participants.

Additionally, the Safe RESEARCH Act seeks to improve the reporting and monitoring of adverse events that may occur during research studies. This includes requiring researchers to promptly report any adverse events to the appropriate regulatory authorities and to take steps to mitigate any potential harm to participants. Overall, the Safe RESEARCH Act is designed to ensure that research involving human subjects is conducted in a safe and ethical manner, with the ultimate goal of protecting the rights and well-being of research participants.

Congressional Summary of HR 1466

Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act or the Safe RESEARCH Act

This bill prohibits the National Institutes of Health (NIH) from conducting or supporting research on human fetal tissue obtained from an abortion procedure. It also imposes other restrictions on human fetal tissue research.

Under the bill, the NIH may conduct or support research on human fetal tissue only if it was obtained from a stillbirth. Current law allows research on tissue from stillbirths or from spontaneous or induced abortions.

The bill also applies informed consent and other requirements applicable to research on the transplantation of human fetal tissue for therapeutic purposes to all research with human fetal tissue. This includes research on stem cells and other human fetal tissue alternatives.

Additionally, human fetal tissue used for this research must be obtained in accordance with state anatomical gift laws. These laws govern organ and tissue donation for therapeutic, research, and other purposes. Some states already apply anatomical gift laws to human fetal tissue donation.

Currently, executive branch officials may not prohibit the NIH from conducting or supporting research on the transplantation of human fetal tissue for therapeutic purposes. The bill repeals this limitation on executive branch officials. It also repeals a requirement that the NIH fund certain proposals for this research.

Current Status of Bill HR 1466

Bill HR 1466 is currently in the status of Bill Introduced since March 8, 2023. Bill HR 1466 was introduced during Congress 118 and was introduced to the House on March 8, 2023.  Bill HR 1466's most recent activity was Referred to the Subcommittee on Health. as of March 17, 2023

Bipartisan Support of Bill HR 1466

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
38
Democrat Cosponsors
0
Republican Cosponsors
38
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 1466

Primary Policy Focus

Health

Potential Impact Areas

- Abortion
- Administrative law and regulatory procedures
- Cell biology and embryology
- Department of Health and Human Services
- Medical research
- Organ and tissue donation and transplantation
- Research administration and funding

Alternate Title(s) of Bill HR 1466

Safe RESEARCH Act
Safe RESEARCH Act
Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act
To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.

Comments